GlassScriptPhysician profile
Walter Richard Delgaudio
NPI 1730270968
$6,497.28
in general payments reported to CMS, 2019-2025
33 companies · $713 in 2025
The $713 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,699 · 2020: $590 · 2021: $357 · 2022: $209 · 2023: $1,217 · 2024: $712 · 2025: $713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,642.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,642.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,180.07 | 2019-2020 | |
| Astellas Pharma US INC | $928.08 | 2019-2025 | Xtandi, Veozah |
| Abbvie INC. | $591.98 | 2019-2025 | Botox, Lupron Depot |
| Sumitomo Pharma America, INC. | $363.32 | 2023-2025 | Gemtesa, Orgovyx |
| Myriad Genetic Laboratories, INC. | $348.58 | 2022-2025 | Prolaris |
| Medtronic, INC. | $290.51 | 2021-2023 | Interstim |
| Pfizer INC. | $268.95 | 2019-2025 | |
| Axonics, INC. | $151.09 | 2020-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $139.18 | 2019-2025 | Spaceoar Vue System - 10ml, Axonics, Rezum Generator |
| Bayer Healthcare Pharmaceuticals INC. | $125.85 | 2023-2025 | |
| Janssen Biotech, INC. | $123.51 | 2023-2025 | Erleada, Akeega |
| Allergan, INC. | $109.18 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $87.73 | 2019-2020 | |
| Urogen Pharma, INC. | $82.77 | 2022-2024 | Jelmyto |
| Teleflex LLC | $76.00 | 2023-2025 | Urolift, Barrigel |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $71.48 | 2025 | |
| Coloplast Corp | $64.45 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $62.03 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $50.17 | 2024-2025 | Keytruda, Lynparza, Lenvima |
| 180 Medical, INC. | $48.80 | 2023-2024 | Speedicath |
| Laborie Medical Technologies Corp. | $41.84 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $39.18 | 2019 | |
| Progenics Pharmaceuticals, INC. | $37.52 | 2023-2025 | Pylarify |
| Palette Life Sciences, INC. | $32.58 | 2022 | |
| Millicent US INC | $32.46 | 2025 | Intrarosa, Femlyv |
| Myovant Sciences INC. | $23.93 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $22.53 | 2023 | Seglentis |
| Bioprotect Medical, INC. | $20.03 | 2025 | Bioprotect Balloon Implant System |
| Endo Pharmaceuticals INC. | $17.46 | 2024 | Aveed, Xiaflex |
| Calyxo, INC. | $17.14 | 2025 | Cvac Aspiration System |
| Cook Medical LLC | $17.03 | 2023 | Cook |
| Olympus America INC. | $16.60 | 2025 | Bovie |
| Amgen INC. | $15.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Delgaudio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.